 |
| MMWR Early Release Vol. 65, Early Release May 03, 2016 |
| In this report |
| Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2–5 Years — United States, 2008–2014 Susanna N. Visser, DrPH; Melissa L. Danielson, MSPH; Mark L. Wolraich, MD; et al. MMWR Morb Mortal Wkly Rep 2016;65:(Early Release) The American Academy of Pediatrics 2011 guidelines recommend “behavior therapy” over medication as first-line treatment for children aged 4–5 years with attention deficit/hyperactivity disorder (ADHD). CDC analyzed Medicaid and employer-sponsored insurance (ESI) claims to assess national and state-level ADHD treatment patterns among young children. Among insured children aged 2–5 years receiving clinical care for ADHD, medication treatment was more common than receipt of recommended first-line treatment with psychological services. Among children with ADHD who had ESI, receipt of psychological services did not increase after release of the 2011 guidelines. |
| MMWR Masthead |
| Department of Health and Human Services Centers for Disease Control and Prevention |
|
The CDC has reached over 1 million email subscribers. Thank you for your support. Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates Questions or problems? Please contact support@xxxxxxxxxxxxxxx. |
   |
   |
| This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636) |  |
